292 related articles for article (PubMed ID: 34764182)
1. Nebulised liposomal amphotericin-B as maintenance therapy in allergic bronchopulmonary aspergillosis: a randomised, multicentre trial.
Godet C; Couturaud F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Bourdin A; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Bergeron A; Gondouin A; Frat JP; Flament T; Camara B; Priou P; Brun AL; Laurent F; Ragot S; Cadranel J; ; Godet C; Couturaud F; Cadranel J; Frat JP; Brun AL; Laurent F; Marchand-Adam S; Pison C; Gagnadoux F; Blanchard E; Taillé C; Philippe B; Hirschi S; Andréjak C; Chenivesse C; Dominique S; Bassinet L; Murris-Espin M; Rivière F; Garcia G; Caillaud D; Blanc FX; Goupil F; Gondouin A; Flament T; Camara B; Priou P; Ragot S
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34764182
[TBL] [Abstract][Full Text] [Related]
2. [Allergic bronchopulmonary aspergillosis: Evaluation of a maintenance therapy with nebulized Ambisome
Godet C; Couturaud F; Ragot S; Laurent F; Brun AL; Bergeron A; Cadranel J;
Rev Mal Respir; 2017 May; 34(5):581-587. PubMed ID: 28552257
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA.
Godet C; Meurice JC; Roblot F; Kauffmann-Lacroix C; Verdaguer M; Frat JP; Cadranel J
Eur Respir J; 2012 May; 39(5):1261-3. PubMed ID: 22547734
[No Abstract] [Full Text] [Related]
4. An evaluation of nebulised amphotericin B deoxycholate (Fungizone
Otu AA; Langridge P; Denning DW
Mycoses; 2019 Nov; 62(11):1049-1055. PubMed ID: 31479538
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA).
Chishimba L; Langridge P; Powell G; Niven RM; Denning DW
J Asthma; 2015 Apr; 52(3):289-95. PubMed ID: 25158109
[TBL] [Abstract][Full Text] [Related]
6. Nebulised liposomal amphotericin-B: a promising strategy for preventing ABPA relapse.
Liu Y; Lu HW; Xu JF
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 36137589
[No Abstract] [Full Text] [Related]
7. Reply to: Nebulised liposomal amphotericin-B: a promising strategy for preventing ABPA relapse.
Godet C; Cadranel J; Frat JP; Ragot S; Couturaud F
Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 36137593
[No Abstract] [Full Text] [Related]
8. A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis.
Ram B; Aggarwal AN; Dhooria S; Sehgal IS; Garg M; Behera D; Chakrabarti A; Agarwal R
J Asthma; 2016 Jun; 53(5):517-24. PubMed ID: 26666774
[TBL] [Abstract][Full Text] [Related]
9. Nebulized amphotericin B for preventing exacerbations in allergic bronchopulmonary aspergillosis: A systematic review and meta-analysis.
Muthu V; Dhooria S; Sehgal IS; Prasad KT; Rudramurthy SM; Aggarwal AN; Chakrabarti A; Agarwal R
Pulm Pharmacol Ther; 2023 Aug; 81():102226. PubMed ID: 37230237
[TBL] [Abstract][Full Text] [Related]
10. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2014 Nov; (11):CD002204. PubMed ID: 25431975
[TBL] [Abstract][Full Text] [Related]
11. Liposomal Amphotericin B Fosters the Corticosteroids' Anti-inflammatory Effect on Murine Allergic Bronchopulmonary Aspergillosis Model Airways.
Fukushima C; Matsuse H; Obase Y; Fukahori S; Tsuchida T; Kawano T; Kohno S; Mukae H
Inflammation; 2019 Dec; 42(6):2065-2071. PubMed ID: 31396817
[TBL] [Abstract][Full Text] [Related]
12. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick H; Southern K
Cochrane Database Syst Rev; 2000; (4):CD002204. PubMed ID: 11034746
[TBL] [Abstract][Full Text] [Related]
13. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002204. PubMed ID: 27820955
[TBL] [Abstract][Full Text] [Related]
14. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2012 Jun; (6):CD002204. PubMed ID: 22696329
[TBL] [Abstract][Full Text] [Related]
15. Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature.
Casciaro R; Naselli A; Cresta F; Ros M; Castagnola E; Minicucci L
J Chemother; 2015 Oct; 27(5):307-11. PubMed ID: 24824366
[TBL] [Abstract][Full Text] [Related]
16. Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis.
Sehgal IS; Agarwal R
J Postgrad Med; 2014; 60(1):41-5. PubMed ID: 24625938
[TBL] [Abstract][Full Text] [Related]
17. A randomised trial of prednisolone
Agarwal R; Muthu V; Sehgal IS; Dhooria S; Prasad KT; Garg M; Aggarwal AN; Chakrabarti A
Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 34503983
[TBL] [Abstract][Full Text] [Related]
18. Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.
Godet C; Goudet V; Laurent F; Le Moal G; Gounant V; Frat JP; Cateau E; Roblot F; Cadranel J
Mycoses; 2015 Mar; 58(3):173-80. PubMed ID: 25690951
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Trial of Itraconazole vs Prednisolone in Acute-Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma.
Agarwal R; Dhooria S; Singh Sehgal I; Aggarwal AN; Garg M; Saikia B; Behera D; Chakrabarti A
Chest; 2018 Mar; 153(3):656-664. PubMed ID: 29331473
[TBL] [Abstract][Full Text] [Related]
20. Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
Wark P; Wilson AW; Gibson PG
Cochrane Database Syst Rev; 2001; (4):CD001108. PubMed ID: 11687098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
